Thymus neoplasm

Related records

Broader conditions (13)

• Cancer or benign tumor
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Endocrine gland neoplasm
• Endocrine system disorder
• Hematologic disorder
• Hematopoietic and lymphoid system neoplasm
• Human disease
• Immune system disorder
• Neoplasm
• Neoplastic disease or syndrome
• Thymus gland disorder

Narrower conditions (38)

• Benign neoplasm of thymus
• Combined thymoma
• Cortical thymoma
• Encapsulated thymoma
• Invasive malignant thymoma
• Lymphoepithelioma-like thymic carcinoma
• Malignant type A thymoma
• Malignant type AB thymoma
• Moderately-differentiated thymic neuroendocrine carcinoma
• Noninvasive malignant thymoma
• Papillary thymic adenocarcinoma
• Poorly differentiated thymic neuroendocrine carcinoma
• Primary mediastinal large B-cell lymphoma
• Thymic adenosquamous carcinoma
• Thymic basaloid carcinoma
• Thymic carcinoma
• Thymic epithelial neoplasm
• Thymic large cell neuroendocrine carcinoma
• Thymic mucoepidermoid carcinoma
• Thymic neuroendocrine carcinoma

Trials (44)

• 18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
• A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies
• A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
• A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor
• A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
• A Study of KC1036 in Patients with Advanced Thymic Tumors
• A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
• A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
• A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
• Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection
• An International Study on Pediatric Patients With Rare Tumors.
• Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
• B-Receptor Signaling in Cardiomyopathy
• Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
• Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
• Cardiac MRI Biomarker Testing (GCC 1618)
• Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
• Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
• Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
• Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies

Drugs in development (13)

• Celecoxib Phase 1
• Cisplatin Phase 3
• Etoposide Phase 3
• Everolimus Phase 2
• Octreotide acetate Phase 2
• Palbociclib Phase 2
• Plicamycin Phase 1
• Prednisone Phase 2
• Ribociclib Phase 2
• Saracatinib Phase 2
• Selinexor Phase 2
• Sunitinib Phase 2
• Thymosin Phase 2